Electrocore LLC
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster … Read more
Market Cap & Net Worth: Electrocore LLC (ECOR)
Electrocore LLC (NASDAQ:ECOR) has a market capitalization of $54.45 Million ($54.45 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23000 globally and #8080 in its home market, demonstrating a 2.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Electrocore LLC's stock price $6.81 by its total outstanding shares 7995903 (8.00 Million).
Electrocore LLC Market Cap History: 2018 to 2026
Electrocore LLC's market capitalization history from 2018 to 2026. Data shows change from $750.82 Million to $54.45 Million (-38.62% CAGR).
Index Memberships
Electrocore LLC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #616 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2029 of 3165 |
Weight: Electrocore LLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Electrocore LLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Electrocore LLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.15x
Electrocore LLC's market cap is 5.15 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $750.82 Million | $992.95K | -$55.82 Million | 756.14x | N/A |
| 2019 | $190.70 Million | $2.39 Million | -$45.15 Million | 79.78x | N/A |
| 2020 | $187.10 Million | $3.50 Million | -$23.51 Million | 53.52x | N/A |
| 2021 | $69.86 Million | $5.45 Million | -$17.22 Million | 12.82x | N/A |
| 2022 | $30.79 Million | $8.59 Million | -$22.16 Million | 3.58x | N/A |
| 2023 | $47.59 Million | $16.03 Million | -$18.83 Million | 2.97x | N/A |
| 2024 | $129.61 Million | $25.18 Million | -$11.89 Million | 5.15x | N/A |
Competitor Companies of ECOR by Market Capitalization
Companies near Electrocore LLC in the global market cap rankings as of March 19, 2026.
Key companies related to Electrocore LLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Electrocore LLC Historical Marketcap From 2018 to 2026
Between 2018 and today, Electrocore LLC's market cap moved from $750.82 Million to $ 54.45 Million, with a yearly change of -38.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $54.45 Million | +51.84% |
| 2025 | $35.86 Million | -72.33% |
| 2024 | $129.61 Million | +172.35% |
| 2023 | $47.59 Million | +54.54% |
| 2022 | $30.79 Million | -55.92% |
| 2021 | $69.86 Million | -62.66% |
| 2020 | $187.10 Million | -1.89% |
| 2019 | $190.70 Million | -74.60% |
| 2018 | $750.82 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Electrocore LLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.45 Million USD |
| MoneyControl | $54.45 Million USD |
| MarketWatch | $54.45 Million USD |
| marketcap.company | $54.45 Million USD |
| Reuters | $54.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.